Nbi-5788

“NBI‑5788” (also known as Tiplimotide) is an altered peptide ligand derived from an immunodominant region (amino acids 83–99) of myelin basic protein (MBP). It was designed to modulate immune activity in multiple sclerosis (MS) by encouraging a shift in T-cell responses toward a T-helper 2 (Th2)-like, anti-inflammatory profile. The directory classifies it as a discontinued API with a peptide source/manufacturing origin. Other names for this substance include Myelin basic protein (83-99), alanyl(83)-lysyl(84)-leucyl(89)-alanyl(91)- 83-Ala-84-Lys-89-Leu-91-Ala-MBP(83-99) and Tiplimotide. Its PubChem CID is 25084501.

CAS No 178823-49-9
Molecular Formula C87H142N24O21
Molecular Weight 1860.2 g/mol
Synonyms (2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2R)-2-aminopropanoyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]propanoyl]amino]-4-oxobutanoyl]amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

Frequently Asked Questions